Identification and quantitation of 5-fluoro-ADB, one of the most dangerous synthetic cannabinoids, in the stomach contents and solid tissues of a human cadaver and in some herbal products

[1]  O. Suzuki,et al.  Postmortem distribution of α-pyrrolidinobutiophenone in body fluids and solid tissues of a human cadaver. , 2014, Legal medicine.

[2]  Y. Shimokawa,et al.  Chemical analysis of a benzofuran derivative, 2-(2-ethylaminopropyl)benzofuran (2-EAPB), eight synthetic cannabinoids, five cathinone derivatives, and five other designer drugs newly detected in illegal products , 2014, Forensic Toxicology.

[3]  O. Suzuki,et al.  A large amount of new designer drug diphenidine coexisting with a synthetic cannabinoid 5-fluoro-AB-PINACA found in a dubious herbal product , 2014, Forensic Toxicology.

[4]  O. Suzuki,et al.  Identification and quantitation of a new cathinone designer drug PV9 in an “aroma liquid” product, antemortem whole blood and urine specimens, and a postmortem whole blood specimen in a fatal poisoning case , 2014, Forensic Toxicology.

[5]  O. Suzuki,et al.  Postmortem distribution of α-pyrrolidinovalerophenone and its metabolite in body fluids and solid tissues in a fatal poisoning case measured by LC–MS–MS with the standard addition method , 2014, Forensic Toxicology.

[6]  T. Shinozuka,et al.  A case of death caused by abuse of a synthetic cannabinoid N-1-naphthalenyl-1-pentyl-1H-indole-3-carboxamide , 2014, Forensic Toxicology.

[7]  O. Suzuki,et al.  Postmortem distribution of AB-CHMINACA, 5-fluoro-AMB, and diphenidine in body fluids and solid tissues in a fatal poisoning case: usefulness of adipose tissue for detection of the drugs in unchanged forms , 2014, Forensic Toxicology.

[8]  H. Shiraishi,et al.  A fatal case of 3,4-methylenedioxypyrovalerone poisoning: coexistence of α-pyrrolidinobutiophenone and α-pyrrolidinovalerophenone in blood and/or hair , 2013, Forensic Toxicology.

[9]  S. Ohta,et al.  A fatal case of MAM-2201 poisoning , 2013, Forensic Toxicology.

[10]  O. Suzuki,et al.  Sensitive determination of ethylene glycol, propylene glycol and diethylene glycol in human whole blood by isotope dilution gas chromatography–mass spectrometry, and the presence of appreciable amounts of the glycols in blood of healthy subjects , 2013, Forensic Toxicology.

[11]  H. Shiraishi,et al.  Time-course profile of urinary excretion of intravenously administered α-pyrrolidinovalerophenone and α-pyrrolidinobutiophenone in a human , 2013, Forensic Toxicology.

[12]  Satoru Matsuda,et al.  Erratum to: Two new synthetic cannabinoids, AM-2201 benzimidazole analog (FUBIMINA) and (4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)methanone (MEPIRAPIM), and three phenethylamine derivatives, 25H-NBOMe 3,4,5-trimethoxybenzyl analog, 25B-NBOMe, and 2C-N-NBOMe, identified in illegal products , 2013, Forensic Toxicology.

[13]  Heesun Chung,et al.  Synthetic cannabinoids abused in South Korea: drug identifications by the National Forensic Service from 2009 to June 2013 , 2013, Forensic Toxicology.

[14]  Satoru Matsuda,et al.  Two new synthetic cannabinoids, AM-2201 benzimidazole analog (FUBIMINA) and (4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)methanone (MEPIRAPIM), and three phenethylamine derivatives, 25H-NBOMe 3,4,5-trimethoxybenzyl analog, 25B-NBOMe, and 2C-N-NBOMe, identified in illegal products , 2013, Forensic Toxicology.

[15]  Y. Goda,et al.  Changes in the prevalence of synthetic cannabinoids and cathinone derivatives in Japan until early 2012 , 2012, Forensic Toxicology.

[16]  D. Zuba,et al.  Analysis of the prevalence and coexistence of synthetic cannabinoids in “herbal high” products in Poland , 2012, Forensic Toxicology.

[17]  K. Kudo,et al.  Construction of calibration-locking databases for rapid and reliable drug screening by gas chromatography-mass spectrometry , 2009, Forensic Toxicology.

[18]  E. Bonilla.  Flameless atomic absorption spectrophotometric determination of manganese in rat brain and other tissues. , 1978, Clinical chemistry.